Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to... see more

TSXV:BTI - Post Discussion

Bioasis Technologies Inc. > Sorry, now 19¢...
View:
Post by JDavenport on Aug 30, 2022 12:31pm

Sorry, now 19¢...

EOM
Comment by narmac on Aug 30, 2022 12:54pm
Ohhhhhhh,,,,,,,,,cant we all feel that rumble beneath our feet on this one??.....or do some posters here have some sort of neurological disorder,,,,,,wait,,,!!!!!,,,,,,,,we can fix that by the dickens!!,,,,but it might be too late to get in then!!!!!,,,,,,,,,,and its,,,,,,,,,,,,,,,,BTI too   dahhhhhhhhhhh mooooooooooooooooooooon!!!!!!,,,DrDR and Mei Mei for Nobel prizes ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities